Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.94% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 11.27% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Canadian Natural Resources
CNQ
$96.9B
| $39.9M | 0.04% |
+2,436,940
| New | +$37.9M |
|
|
GWR
352
DELISTED
Genesee & Wyoming Inc.
GWR
| $39.7M | 0.04% |
413,447
+12,251
| +3% | +$1.18M |
|
353
Pebblebrook Hotel Trust
PEB
$2.18B
| $39.4M | 0.04% |
1,281,630
-49,287
| -4% | -$1.45M |
|
354
Western Midstream Partners
WES
$19.4B
| $39.3M | 0.04% |
993,830
| – | – |
|
355
Acadia Pharmaceuticals
ACAD
$4.51B
| $39.1M | 0.04% |
1,563,551
+50,359
| +3% | +$1.19M |
|
356
Dorman Products
DORM
$4.22B
| $39M | 0.04% |
694,792
+57,056
| +9% | +$2.87M |
|
|
RRTS
357
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $38.9M | 0.04% |
57,678
-22,318
| -28% | -$14.8M |
|
358
Hilton Worldwide
HLT
$72.4B
| $38.9M | 0.04% |
+582,045
| New | +$38.1M |
|
|
ULTI
359
DELISTED
Ultimate Software Group Inc
ULTI
| $38.1M | 0.04% |
248,929
-2,764
| -1% | -$418K |
|
360
Alamos Gold
AGI
$12B
| $37.9M | 0.04% |
3,130,870
+6,798
| +0.2% | +$91.9K |
|
361
Huron Consulting
HURN
$2.71B
| $37.8M | 0.04% |
603,116
-24,608
| -4% | -$1.44M |
|
|
CIE
362
DELISTED
Cobalt International Energy, Inc
CIE
| $37.3M | 0.04% |
151,311
-338,598
| -69% | -$106M |
|
|
HMHC
363
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $36.7M | 0.04% |
+2,161,988
| New | +$36.5M |
|
|
UTX.PRA
364
DELISTED
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
| $36.7M | 0.04% |
560,000
| – | – |
|
|
WBMD
365
DELISTED
WebMD Health Corp.
WBMD
| $36.6M | 0.04% |
+927,656
| New | +$33.5M |
|
366
FedEx
FDX
$73B
| $36.5M | 0.04% |
253,729
-523,594
| -67% | -$69.3M |
|
367
Molson Coors Class B
TAP
$8.02B
| $36.3M | 0.04% |
646,802
-105,627
| -14% | -$5.65M |
|
|
BSFT
368
DELISTED
BroadSoft, Inc.
BSFT
| $36.3M | 0.04% |
1,328,048
-169,881
| -11% | -$5.03M |
|
|
ENLC
369
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $36.1M | 0.04% |
+999,330
| New | +$29.8M |
|
370
Live Nation Entertainment
LYV
$42.9B
| $36.1M | 0.04% |
1,828,478
-292,718
| -14% | -$5.48M |
|
|
KSU
371
DELISTED
Kansas City Southern
KSU
| $36M | 0.04% |
290,424
-642,975
| -69% | -$76.9M |
|
372
Asbury Automotive
ABG
$4.62B
| $35.9M | 0.04% |
667,202
-329,192
| -33% | -$17M |
|
|
CNL
373
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $35.8M | 0.04% |
766,862
| – | – |
|
374
Eldorado Gold
EGO
$8.33B
| $35.7M | 0.04% |
1,258,898
-1,061,382
| -46% | -$32.5M |
|
|
BRCD
375
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $35.4M | 0.03% |
3,993,203
-518,893
| -12% | -$4.33M |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.